| 发明名称 |
Multiple-delayed release anti-neoplastic product, use and formulation thereof |
| 摘要 |
An anti-neoplastic product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the C<SUB>max </SUB>for the anti-neoplastic product being reached in less than about twelve hours after initial release of anti-neoplastic from the product.
|
| 申请公布号 |
US7105174(B2) |
申请公布日期 |
2006.09.12 |
| 申请号 |
US20020211035 |
申请日期 |
2002.08.02 |
| 申请人 |
ADVANCIS PHARMACEUTICAL CORPORATION |
发明人 |
RUDNIC EDWARD M.;ISBISTER JAMES D.;TREACY, JR. DONALD J.;WASSINK SANDRA E. |
| 分类号 |
A61K9/00;A61K9/14;A61K9/20;A61K9/22;A61K9/48;A61K9/50;A61K9/52 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
